#neglected-tropical-disease
Issues, solutions, and case studies for neglected-tropical-disease
Found 8 nodes with this tag: 2 issues · 3 solutions · 3 case studies
Related tags:
Issues 2
#00133Antivenoms are species- and region-specific, so the available product often fails against the local snake
Because venom composition varies by species, geography, and age, antivenom raised against one region's snakes frequently fails to neutralize bites elsewhere, and many medically important species have no effective product at all — a scientific matching problem distinct from cost o
#00074Snakebite envenoming kills and disables hundreds of thousands each year in the rural tropics
Rural farming and herding communities across tropical Asia, sub-Saharan Africa and Latin America suffer an estimated 1.8–2.7 million envenomings a year, causing roughly 81,000–138,000 deaths and 300,000–400,000 permanent disabilities — despite envenoming being a treatable medical
Solutions 3
#00138Cut time-to-treatment with community education and organised rapid transport
Combine community health education (discouraging traditional-healer delay, teaching safe first aid) with organised volunteer rapid transport — e.g., motorcycle networks — to get envenomed patients to an antivenom-equipped centre within the window that determines survival.
#00134Deploy repurposed small-molecule toxin inhibitors as broad-spectrum early therapy
Use varespladib (PLA2 inhibitor), marimastat (SVMP inhibitor), and DMPS/dimercaprol (Zn2+ chelators) as cheap, heat-stable, species-agnostic first-line treatment that buys time before or alongside antivenom, particularly in the pre-hospital window.
#00131Replace animal-derived antivenom with broadly-neutralizing recombinant human antibody cocktails
Manufacture antivenom as a defined cocktail of recombinant human monoclonal antibodies targeting conserved toxin families (3FTx, PLA2, SVMP, SVSP), replacing dozens of narrow regional polyclonal sera with a small number of broad-spectrum products split roughly by neurotoxic-elapi
Case studies 3
Sharma et al. study team with local motorcycle-volunteer network and the Damak Red Cross Society treatment centre · Region
In four villages of southeastern Nepal (population ~62,000, Jhapa/Morang region), where most neurotoxic-envenoming deaths occurred in the village or during transport, a study team combined community health education (di…
1 source
Ophirex, Inc. (sponsor), with emergency-department sites in India and the USA · 2021–2022 · National
BRAVO was a double-blind, randomised, placebo-controlled phase II trial of oral varespladib-methyl plus standard care (including antivenom) versus standard care plus placebo, run in emergency departments in India (Puduc…
1 source
Centivax, Inc.; Columbia University; NIAID (US National Institute of Allergy and Infectious Diseases) · Global
Researchers isolated broadly-neutralizing IgG antibodies from the memory B-cells of a human donor (Tim Friede) who had self-immunized with escalating venom doses from 16 lethal elapid species over ~18 years. Two antibod…
2 sources